Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The thread of life -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (483)	6/6/2003 10:37:21 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 1336

Lentivirus-based gene transfer vectors United States Patent 6,521,457 Inventors: Olsen; John C. (Chapel Hill, NC) Assignee: University of North Carolina at Chapel Hill (Chapel Hill, NC) Just poking around. Clearly this is not the way to exploit the patent database: Results of Search in 1976 to present db for: (VSV-G AND Lentivirus): 38 patents. Hits 1 through 38 out of 38 What makes one lab's vector better than another? Successful studies in primates. No idea what companies have licenses for this stuff. CEGE probably.

To: Mike McFarland who wrote (483)	6/7/2003 5:23:17 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 1336

More misc lentivirus stuff United States Patent 5,665,577 Sodroski (includes Haseltine et al) September 9, 1997 Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof Assignee: Dana-Farber Cancer Institute (Boston, MA) Appl. No.: 152902 Filed: November 15, 1993 I found that patent by working back from a company PR that had a license. I've never heard of Genetix or Tranzyme...I suspect they're not in the same league as some of the others on this surprising long list of "Gene Therapy Players". biophoenix.com